Ayurveda Medicine for the management of COVID-19

Efficacy study of Ayurveda dosage forms for the management of COVID-19 - AYUMACOV

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036380

Enrollment

168

Registered

2021-09-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: i. Patients able to take medicines orally. ii. Patients willing to provide signed informed consent shall be included. iii. RT-PCR (Reverse transcription polymerase chain reaction) positive patients

Exclusion criteria

Exclusion criteria: i. Subjects with severe vomiting which would affect oral administration of medicine difficult. ii. Moderate and severe cases. iii. Pregnant and lactating subjects. iv. Subjects with Type 1 diabetes, malignancy and those with advanced liver or kidney disease. v. The initially included subjects who during the course of treatment progress from mild to moderate category in severity.

Design outcomes

Primary

Measure	Time frame
1. All-cause mortality 2. WHO Ordinal Scale for Clinical Improvement of COVID-19Timepoint: 1 year	—

Secondary

Measure	Time frame
1. Virological clearance of nasopharyngeal samples 2. Admission to critical care unit 3. Need for supplemental oxygen, mechanical ventilation/oxygenation or ECLS 4. Need for intravenous vasoactive medications 5. Need for renal replacement therapy 6. Hospital-free days, ICU-free daysTimepoint: 1 year	—

Countries

India

Contacts

Public ContactDr Deepak Gautam

Institute of Medical Sciences, Banaras Hindu University

krcreddy@bhu.ac.in9415813533

Outcome results